Dr Leen Kawas is not a new name in the pharmaceutical world. The scientist and respected professional cofounded Athira Pharma several years ago. A few years later, the company introduced ATH-1017, a popular drug candidate. Leen Kawas worked as the president and chief executive officer of Athira for a long time. The businesswoman was a member of the board of directors too. In her tenure as president and CEO, Kawas led the financial and technological growth of the firm. By 2021, the firm was worth over four hundred million. The Business Insider recognized Kawas as one of the top 22 female chief executive officers and founders helping their companies IPO.
When Leen Kawas left Athira Pharma in 2021, one of the earliest and most respected investors reached out because he wanted to form a new partnership. Kawas agreed to the idea, and she travelled to LA in one week for the new business venture. The trip led to the foundation of M3 Biotechnology, a fast-growing institution in the United States.
Becoming a successful entrepreneur in modern society is not a walk in the park. Kawas believes she has been doing well because of having three essential skills. First, Kawas can make crucial decisions about business with conviction. The businesswoman can also operate using analytical, innovative and strategic thinking. Leen doesn’t give up easily when dealing with challenges. When creating her teams, Kawas ensures she is surrounded by growth-minded individuals who do not give up quickly too.
The scientist has numerous plans for the future of her company. Leen believes she will search for the most innovative scientists and entrepreneurs to help create advanced technologies. Kawas wants to work with creative minds who wish to develop excellent therapies to help consumers live happier, smarter, healthier lives.
Dealing with competitors is easy for Leen because she is experienced and very creative in the biotechnology industry.
Original source to learn more: https://www.inherentbio.com/team/leen-kawas